Description
Cimzia is a monoclonal antibody that binds to and inhibits the activity of tumor necrosis factor (TNF) alpha, a protein that is involved in systemic inflammation. By stopping TNF alpha-mediated signaling, the inflammation that contributes to the development of autoimmune disorders like rheumatoid arthritis and ankylosing spondylitis is reduced and associated symptoms are improved
